Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Oncology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Your Unread Messages

Medicare Final Rule for 2010
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Using Embryonic Stem Cells to Test Breast Cancer Genes
Sara Hartley, MDLinx Oncology
Technology Advances: Nanotech PSA Levels Unmask Lingering Prostate Cancer
Dorothy J. Schirf, MD, MDLinx Oncology
  See all

Articles: Leukemia/Lymphoma



Latest (7) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapy
Leukemia and Lymphoma, 10/30/09
Sponsor
Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL + cell to Imatinib and Nilotinib
Leukemia and Lymphoma, 10/30/09
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas
Leukemia and Lymphoma, 10/30/09
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma
Leukemia and Lymphoma, 10/30/09
Protein kinase C-beta II expression in diffuse large B-cell lymphoma predicts for inferior outcome of anthracycline-based chemotherapy with and without rituximab
Leukemia and Lymphoma, 10/30/09
A prospective study of left ventricle function after treatment with rapid-infusion Rituximab in patients with non-Hodgkin lymphoma
Leukemia and Lymphoma, 10/30/09
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up
Leukemia and Lymphoma, 10/30/09
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691
Leukemia and Lymphoma, 10/30/09
Functional signatures identified in B-cell non-Hodgkin lymphoma profiles
Leukemia and Lymphoma, 10/30/09
Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood
Leukemia and Lymphoma, 10/30/09
T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy cell leukemia correlates with interferon-gamma production
Leukemia and Lymphoma, 10/30/09
Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09
VMP (bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: Cohort analysis of the phase III Vista study
Journal of Clinical Oncology, 10/29/09
Management of relapse after allo-SCT for AML and the role of second transplantation
Bone Marrow Transplantation, 10/29/09
Exclusive Author Commentary
High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis
Annals of Oncology, 10/29/09
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
Annals of Oncology, 10/29/09
Acute pulmonary failure during remission induction chemotherapy in adults with acute myeloid leukemia or high-risk myelodysplastic syndrome
Cancer, 10/29/09
When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type
Annals of Oncology, 10/29/09
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL
Bone Marrow Transplantation, 10/29/09
Primary cardiac lymphoma: B- and T-cell cases at a specialist UK centre
Annals of Oncology, 10/29/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
250 Available Pages
First    Prev    5      6      7      8      9      10      11      12      13      14      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.